Evidence map›Paper›PMID 37854418›Full record

ArticleGlobal mental health (Cambridge, England)2023

The COVID-19 pandemic and mental health in Kazakhstan.

Gaukhar Mergenova, Susan L Rosenthal, Akbope Myrkassymova, Assel Bukharbayeva, Balnur Iskakova, Aigulsum Izekenova, Assel Izekenova, Lyailya Alekesheva, Maral Yerdenova, Kuanysh Karibayev and 3 more

Abstract read
In one paragraph

Article in Global mental health (Cambridge, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Gaukhar MergenovaGlobal Health Research Center of Central Asia, Almaty, Kazakhstan.ORCID https://orcid.org/0000-0003-4702-1944
Susan L RosenthalDepartment of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
Akbope MyrkassymovaAsfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Assel BukharbayevaAsfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Balnur IskakovaAsfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Aigulsum IzekenovaAsfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Assel IzekenovaKenzhegali Sagadiyev University of International Business, Almaty, Kazakhstan.
Lyailya AlekeshevaAsfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Maral YerdenovaAsfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Kuanysh KaribayevAsfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Baurzhan ZhussupovAsfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Gulzhan AlimbekovaCIOM (Public Opinion Research Centre), Almaty, Kazakhstan.
Alissa DavisColumbia University School of Social Work, New York, NY, USA.

Funding

Research Training for Substance Use Mediated HIV Epidemic in Kazakhstan/Aging SupplementD43TW010046 · FIC · SUNY DOWNSTATE MEDICAL CENTER · PI Jack A DeHovitz, Zhamilya Nugmanova · 2016 to 2026
$3.4M
FIC NIH HHS D43 TW010046
6 · The paper itself

Abstract

The COVID-19 pandemic had significant impacts on mental health. We examined factors associated with symptoms of depression and anxiety during the COVID-19 pandemic in Kazakhstan. We surveyed 991 adults in Kazakhstan in July 2021 using multistage stratified sampling. Depression and anxiety were measured with the Patient Health Questionnaire-4. We conducted logistic regression to assess associations between depression and anxiety and sociobehavioral factors. Overall, 12.01% reported depressive symptoms and 8.38% anxiety. Higher likelihood of depression was associated with being female (AOR: 1.64; 95% CI [1.05, 2.55]), having experience with COVID-19 in the social environment (AOR: 1.85; 95% CI [1.1-3.14]), experiencing food insecurity (AOR: 1.80; 95% CI [1.11-2.89]), increased family conflict (AOR: 2.43; 95% CI [1.32-4.48]) and impaired healthcare access (AOR: 2.41; 95% CI [1.32-4.41]). Higher likelihood of anxiety was associated with being female (AOR: 3.43; 95% CI [1.91-6.15]), increased family conflict (AOR: 2.22; 95% CI [1.11-4.44]) and impaired healthcare access (AOR: 2.63; 95% CI [1.36-5.12]). Multiple factors were associated with mental health in Kazakhstan during the COVID-19 pandemic. Further research is needed to determine the extent to which these factors and their associated mental health outcomes may persist.

Indexed as

anxietyCOVID-19depressionlow and middle-income countriesmental health

Identifiers

PMID37854418
PMCPMC10579662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.